Insulin Glargine (U-300) Pens and Xpovio (80 MG Twice Weekly)
Determining the interaction of Insulin Glargine (U-300) Pens and Xpovio (80 MG Twice Weekly) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: selinexor
Brand name: Xpovio
Synonyms: Xpovio
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-300) Pens-Xryliderm
- Insulin Glargine (U-300) Pens-Xrylix
- Insulin Glargine (U-300) Pens-Xtampza ER
- Insulin Glargine (U-300) Pens-Xtandi
- Insulin Glargine (U-300) Pens-Xtramins
- Insulin Glargine (U-300) Pens-Xtrelus
- Xpovio (80 MG Twice Weekly)-Insulin glargine and lixisenatide
- Xpovio (80 MG Twice Weekly)-Insulin glargine and lixisenatide Subcutaneous
- Xpovio (80 MG Twice Weekly)-Insulin glargine, recombinant Subcutaneous
- Xpovio (80 MG Twice Weekly)-Insulin glulisine
- Xpovio (80 MG Twice Weekly)-Insulin Glulisine (Cartridges and Pens)
- Xpovio (80 MG Twice Weekly)-Insulin Glulisine (Vials)